Address: Eli Lilly and Company (India) pvt. Ltd., Plot# 92, Sector 32, Institutional Area, Gurgaon-122001, HARYANA, INDIA ,India
Tel: 91-124-4753000, 01
Web: https://www.lillyindia.co.in/
Eli Lilly and Company established its India operations in 1993 as a Joint venture with Ranbaxy Laboratories’ Limited. After the divestiture in 2001 it was Christened Eli Lilly and Company (India) Pvt. Ltd, and is today one of the most admired companies in terms of its focus on scientific selling, unique bouquet of products and services, working environment and focus on Ethics and Compliance Lilly India provides innovative answers to the needs of the people suffering from Diabetes, Cancer, Sepsis, Osteoporosis, Cardiovascular disorders and Growth hormone deficiency.
Major Achievements of Eli Lilly and Company (India) Pvt. Ltd.
In top 25 “Great Places to Work For in India” in 2003 and 2004 in a survey conducted by ‘Great Places to Work’ Institute
In top 25 in 2003 “Best Employers in India” in a survey conducted by Hewitt Associates.
2nd Best company to work for under ‘Biotech & Pharmaceutical’ category in 2008 in a survey conducted by Great Places to Work Institute USA’.
In top 10 “Best Companies to Work for in India’ in Business Today-Mercer-TNS survey 2008. Ranked 9th overall, achieving the unique distinction of being the only Pharmaceutical Company in this list.
We strive to touch the lives of our customers by actively listening and responding to their needs with breakthrough products and medical expertise that is critical to their understanding and treatment of diseases.
Looking back at the company’s recent challenges, we see a very tough 2009, largely due to the Betapharm acquisition and the subsequent changes in German regulations. How do you explain…
Since the company’s foundation in 1993, Hetero has clearly come a long way. What were the key success factors at that time, which laid the groundwork of a successful company?…
Over the years, multinational corporations (MNCs) have increasingly been penetrating the Indian pharmaceutical markets. How have you observed this trend throughout your career? Based on India’s macro-economic growth of around…
India is clearly a new location for Cockram, and what brought you here was your loyal customer Pfizer. After 3 years of project work, a permanent business has now also…
Dilip Surana of family-run Indian generics giant Micro Labs talks company performance, the evolution of the Indian pharma market, and strategy moving forward. Last year Micro Labs moved up in…
Having been director here in India between 1998-2002, and then again since 2006, you have clearly been in the front seat to observe the evolution of the Indian market. How…
Looking back at the company’s recent challenges, we see a very tough 2009, largely due to the Betapharm acquisition and the subsequent changes in German regulations. How do you explain…
You have very successfully executed a vision that you have had for the company since it was a 200 Rs Cr turnover, India-focused enterprise 15 years ago. You have had…
When Astellas announced to expand its presence in India in 2009, you were already speaking of the company’s long commitment and solid relationship with India. Can you elaborate on these…
What probably best explains the contrasts in the Indian pharmaceutical landscape is the fact that India can take many shapes and forms and that different companies in India will keep…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching up with the Western…
For decades now, ACG has been building up its reputation in the global pharma space. The Indian Pharma industry, at the same time, increasingly is catching up with the Western…
See our Cookie Privacy Policy Here
